News

According to the company, the new system comprises 14 updates that provide improved patient safety measures and features. ExactaMix ACDs automatically compound multi-ingredient sterile doses, reducing the risk

Health Canada has granted Optimer priority review of the Dificid NDS, reducing the time to a potential regulatory approval in Canada. The NDS is based on the results

ISIS-GCGRRx blocks the glucagon receptor (GCGR) and reduces amount of glucose producing harmone in the liver – glucagon. Isis COO, CFO and secretary Lynne Parshall said their ISIS-GCGRRx

Morrissey will act as an executive for small-cap start-ups and as a medical professional for the growth of nutraceutical market. She served at medical and dental clinics and

The objective of extending collaboration is to identify, develop and commercialize drugs to treat neurodegenerative diseases, ophthalmology and pain. Exonhit CEO Loic Maurel said the collaboration has created

CK-2017357 is a skeletal muscle troponin activator which increases its sensitivity to calcium and delays the onset and reduces the degree of muscle fatigue. The double-blind, placebo-controlled, randomized,

Under the agreement, Evonik will acquire the complete portfolio of products and services of SurModics Pharmaceuticals, including the company’s cGMP development and manufacturing facility situated in Birmingham, Alabama.

The tumor-targeting system, which will use human autoimmune antibodies, is expected to enhance the safety and effectiveness of current cancer drugs by improving localization at the tumor site.

Epinastine HCl is a generic version of Merck’s eye drug Elestat. Elestat comprises epinastine used to prevent ocular itching associated with allergic conjunctivitis. Perrigo chairman and CEO Joseph